Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Galera Therapeutics, Inc. (GRTX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Galera Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Galera Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is GRTX. The reporting company's CIK number is 1563577.
The total value of stock buying since 2005 is $28,999,992.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-12||Clarus Iv Gp L.p. (10% Owner)||Buy||250,000||12.00||3,000,000|
|2019-11-12||Mehra Anand (10% Owner)||Buy||750,000||12.00||9,000,000|
|2019-11-12||Novo Holdings A/s (Other)||Buy||500,000||12.00||6,000,000|
|2019-11-12||Sandell Scott D (10% Owner)||Buy||416,666||12.00||4,999,992|
|2019-11-12||Novartis Ag (10% Owner)||Buy||250,000||12.00||3,000,000|
|2019-11-12||Schwarzman Stephen A (10% Owner)||Buy||250,000||12.00||3,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises of GRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Galera Therapeutics, Inc. (symbol GRTX, CIK number 1563577) see the Securities and Exchange Commission (SEC) website.